JP2009533428A - 筋肉内抗ウイルス処置 - Google Patents

筋肉内抗ウイルス処置 Download PDF

Info

Publication number
JP2009533428A
JP2009533428A JP2009505338A JP2009505338A JP2009533428A JP 2009533428 A JP2009533428 A JP 2009533428A JP 2009505338 A JP2009505338 A JP 2009505338A JP 2009505338 A JP2009505338 A JP 2009505338A JP 2009533428 A JP2009533428 A JP 2009533428A
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009505338A
Other languages
English (en)
Japanese (ja)
Inventor
ヤーラガッダ エス． バブ，
プーラン チャンド，
シャンタ バンティア，
シェーン アーノルド，
ジョン マイケル キルパトリック，
Original Assignee
バイオクライスト ファーマシューティカルズ， インコーポレイテッド
ヤーラガッダ エス． バブ，
プーラン チャンド，
シャンタ バンティア，
シェーン アーノルド，
ジョン マイケル キルパトリック，
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオクライスト ファーマシューティカルズ， インコーポレイテッド, ヤーラガッダ エス． バブ，, プーラン チャンド，, シャンタ バンティア，, シェーン アーノルド，, ジョン マイケル キルパトリック， filed Critical バイオクライスト ファーマシューティカルズ， インコーポレイテッド
Publication of JP2009533428A publication Critical patent/JP2009533428A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2009505338A 2006-04-12 2006-04-12 筋肉内抗ウイルス処置 Pending JP2009533428A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments

Publications (1)

Publication Number Publication Date
JP2009533428A true JP2009533428A (ja) 2009-09-17

Family

ID=37671157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009505338A Pending JP2009533428A (ja) 2006-04-12 2006-04-12 筋肉内抗ウイルス処置

Country Status (8)

Country Link
JP (1) JP2009533428A (ru)
CN (1) CN104784166A (ru)
AU (1) AU2006341592A1 (ru)
BR (1) BRPI0621552A2 (ru)
CA (1) CA2649090A1 (ru)
EA (1) EA200870430A1 (ru)
MX (1) MX2008013140A (ru)
WO (1) WO2007117241A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010535820A (ja) * 2007-08-14 2010-11-25 インスティテュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシーズ ピー・エル・エイ チャイナ （１ｓ，２ｓ，３ｓ，４ｒ）−３−［（１ｓ）−１−アセチルアミノ−２−エチル−ブチル］−４−グアニジノ−２−ヒドロキシ−シクロペンチル−１−カルボン酸水和物及びその使用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0518443D0 (en) 2005-09-09 2005-10-19 Evolutec Ltd Method of treating myasthenia gravis
AU2011204483B2 (en) * 2010-01-08 2016-02-11 Volution Immuno Pharmaceuticals Sa EV576 for use in the treatment of viral infections of the respiratory tract
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001527058A (ja) * 1997-12-17 2001-12-25 バイオクリスト・ファマシューティカルズ インク． ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001527058A (ja) * 1997-12-17 2001-12-25 バイオクリスト・ファマシューティカルズ インク． ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010535820A (ja) * 2007-08-14 2010-11-25 インスティテュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシーズ ピー・エル・エイ チャイナ （１ｓ，２ｓ，３ｓ，４ｒ）−３−［（１ｓ）−１−アセチルアミノ−２−エチル−ブチル］−４−グアニジノ−２−ヒドロキシ−シクロペンチル−１−カルボン酸水和物及びその使用

Also Published As

Publication number Publication date
EA200870430A1 (ru) 2009-06-30
WO2007117241A1 (en) 2007-10-18
AU2006341592A1 (en) 2007-10-18
BRPI0621552A2 (pt) 2011-12-13
MX2008013140A (es) 2009-02-12
CN104784166A (zh) 2015-07-22
CA2649090A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
JP6012076B2 (ja) インフルエンザ治療剤
KR101422744B1 (ko) （１ｓ，２ｓ，３ｓ，４ｒ）－３－［（１ｓ）－１－아세틸아미노－２－에틸－부틸］－４－구아니디노－２－하이드록시－사이클로펜틸―１－카복실산 하이드레이트 및 이의 약제학적 용도
BRPI0716214A2 (pt) Composições farmacêuticas para o tratamento de infecções fúngicas.
JP2009533428A (ja) 筋肉内抗ウイルス処置
US20180015063A1 (en) Antiviral treatments
JP6073202B2 (ja) 静脈におけるウイルスの治療
JP2009538822A5 (ru)
US20070244193A1 (en) Intramuscular antiviral treatments
KR20080113099A (ko) 근육내 항바이러스 치료
AU2016262644A1 (en) Intravenous antiviral treatments
US20230151034A1 (en) Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120403

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120904